ReSurfX
ReSurfX Inc. is an outcomes intelligence company specializing in highly accurate AI-driven solutions to improve innovation, ROI, and decision-making in life sciences and healthcare. Their flagship product, ReSurfX::vysen, is an enterprise cloud-based SaaS platform leveraging their patented Adaptive Hypersurface Technology (AHT) to deliver superior accuracy, novel insights, and advance prediction of outcome directions from big data initiatives, particularly in gene expression analysis and drug response prediction. The company also offers measurement technology redesigns to improve data quality at the source. ReSurfX's solutions are data-source agnostic and personalized, enabling robust, scalable, and novel analytics that outperform traditional methods. They have received multiple industry accolades and have validated their predictive AI in complex healthcare applications, including FDA-recognized drug interaction predictions. Their business model includes tiered volume-based pricing for their SaaS product and technology redesign services, targeting life sciences, biotech, and healthcare enterprises.
ReSurfX
ReSurfX Inc. is an outcomes intelligence company specializing in highly accurate AI-driven solutions to improve innovation, ROI, and decision-making in life sciences and healthcare. Their flagship product, ReSurfX::vysen, is an enterprise cloud-based SaaS platform leveraging their patented Adaptive Hypersurface Technology (AHT) to deliver superior accuracy, novel insights, and advance prediction of outcome directions from big data initiatives, particularly in gene expression analysis and drug response prediction. The company also offers measurement technology redesigns to improve data quality at the source. ReSurfX's solutions are data-source agnostic and personalized, enabling robust, scalable, and novel analytics that outperform traditional methods. They have received multiple industry accolades and have validated their predictive AI in complex healthcare applications, including FDA-recognized drug interaction predictions. Their business model includes tiered volume-based pricing for their SaaS product and technology redesign services, targeting life sciences, biotech, and healthcare enterprises.